Leukemia inhibitory factor treatment attenuates the detrimental effects of glucocorticoids on bone in mice.
Leukemia inhibitory factor treatment attenuates the detrimental effects of glucocorticoids on bone in mice.
复制标题
白血病抑制因子治疗减轻糖皮质激素对小鼠骨骼的有害影响
DOI:
10.1016/j.bone.2021.115843
复制
发表时间:
2021
期刊:
影响因子:
4.1
通讯作者:
Tuckermann
中科院分区:
文献类型:
--
作者:
Tuckermann
Glucocorticoids (GCs) are widely used drugs for the treatment of inflammatory and autoimmune diseases. However, a severe side effect induced by long-term GC therapy is osteoporosis. Leukemia inhibitory factor (LIF) – a glycoprotein 130 (gp130) dependent cytokine and member of the interleukin-6 cytokine family – is an activator protein 1 (AP-1) target gene that may be involved in one of the mechanisms underlying GC-induced bone loss. Indeed, we previously reported that the mRNA expression level of LIF was enhanced upon osteogenic differentiation, but was significantly decreased in GC-treated osteoblasts. In this study, we show thatin vitroLIF treatment rescues the decreased early osteogenic differentiation and mineralization of GC-treated osteoblasts. Furthermore, we also demonstrate thatin vivoLIF treatment protects against GC-mediated trabecular bone loss by decreasing the loss of both trabecular bone formation and osteoblast numbers. This protection appears to be conferred by LIF rescuing GC decreased activity of Stat3, MAPK, and Akt signaling pathways. Thus, the specific targeting of LIF signaling may represent a new therapeutic strategy to prevent GC-induced trabecular bone loss.
登录
查看更多内容
影响因子:
11.4
作者:
D. Gearing;N. Gough;J. A. King;D. Hilton;N. Nicola;R. Simpson;E. Nice;A. Kelso;D. Metcalf
通讯作者:
D. Metcalf
影响因子:
4.8
作者:
O'Brien, CA;Jia, D;Weinstein, RS
通讯作者:
Weinstein, RS
DOI:
--
发表时间:
2001
期刊:
Journal of cellular biochemistry. Supplement
影响因子:
--
作者:
L. Malaval;J. Aubin
通讯作者:
J. Aubin
影响因子:
13
作者:
Nicola NA;Babon JJ
通讯作者:
Babon JJ
影响因子:
4.1
作者:
Zhou, Hongkang;Newnum, America B.;Li, Jiliang
通讯作者:
Li, Jiliang